Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 12/20 | 0.39 |
| ▸ | MAPK10 | P53779 | 5/20 | 0.39 |
| ▸ | MAPK8 | P45983 | 4/20 | 0.39 |
| ▸ | MAPK9 | P45984 | 4/20 | 0.39 |
| ▸ | JUN | P05412 | 3/20 | 0.39 |
| ▸ | CCNA2 | P20248 | 9/20 | 0.39 |
| ▸ | CCNK | O75909 | 3/20 | 0.39 |
| ▸ | CDK7 | P50613 | 3/20 | 0.39 |
| ▸ | CCNH | P51946 | 3/20 | 0.39 |
| ▸ | MNAT1 | P51948 | 3/20 | 0.39 |
| ▸ | CDK12 | Q9NYV4 | 3/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 6/20 | 0.37 |
| ▸ | CCNA1 | P78396 | 6/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.37 |
| ▸ | CDK4 | P11802 | 1/20 | 0.37 |
| ▸ | CCND1 | P24385 | 1/20 | 0.37 |
| ▸ | KIT | P10721 | 1/20 | 0.35 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10235145 | 0.93 | MAPK8 (0.39) | DYRK1ACDK2MAPK10MAPK8MAPK9 | |
| SCHEMBL10239257 | 0.93 | DYRK1A (0.39) | DYRK1ACDK2CCNA2CCNKCDK7 | |
| SCHEMBL10239242 | 0.91 | CCNA2 (0.41) | DYRK1ACDK2CCNA2CCNKCDK7 | |
| SCHEMBL7879290 | 0.91 | CCNA2 (0.39) | DYRK1ACDK2CCNA2CCNKCDK7 | |
| SCHEMBL10239221 | 0.90 | MAP4K4 (0.40) | DYRK1ACDK2MAPK8CCNA2CCNK | |
| SCHEMBL10239248 | 0.90 | CCNA2 (0.38) | DYRK1ACDK2MAPK8CCNA2CCNK | |
| SCHEMBL7883416 | 0.90 | CCNA2 (0.39) | DYRK1ACDK2CCNA2CCNKCDK7 | |
| SCHEMBL10239230 | 0.89 | CCNA2 (0.38) | DYRK1ACDK2MAPK10MAPK8MAPK9 | |
| SCHEMBL7882822 | 0.89 | CCNA2 (0.38) | DYRK1ACDK2CCNA2CCNKCDK7 | |
| SCHEMBL10239259 | 0.89 | CCNA2 (0.37) | DYRK1ACDK2CCNA2CCNKCDK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120114739-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | MERCK SHARP & DOHME LLC | 2012-05-10 | — | — | US | disclosed |
| US-20120114739-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | MERCK SHARP & DOHME LLC | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120114739-A1 | PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS | MTOR, RICTOR, RPTOR | DYRK1A 3730/4885CDK2 165/4885MAPK10 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.